ABIOMED, Inc. (ABMD): Price and Financial Metrics


Today's Latest Price: $251.88 USD

2.73 (-1.07%)

Updated Oct 30 4:00pm

Add ABMD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

ABMD Stock Summary

  • Abiomed Inc's stock had its IPO on July 30, 1987, making it an older stock than 91.7% of US equities in our set.
  • Price to trailing twelve month operating cash flow for ABMD is currently 40.23, higher than 91.52% of US stocks with positive operating cash flow.
  • The ratio of debt to operating expenses for Abiomed Inc is higher than it is for about only 0.36% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Abiomed Inc are LOGI, FFIV, CGNX, NICE, and PRLB.
  • ABMD's SEC filings can be seen here. And to visit Abiomed Inc's official web site, go to www.abiomed.com.

ABMD Stock Price Chart Interactive Chart >

Price chart for ABMD

ABMD Price/Volume Stats

Current price $251.88 52-week high $319.19
Prev. close $254.61 52-week low $119.01
Day low $242.73 Volume 426,300
Day high $258.18 Avg. volume 569,028
50-day MA $279.67 Dividend yield N/A
200-day MA $227.35 Market Cap 11.35B

ABIOMED, Inc. (ABMD) Company Bio

ABIOMED Inc. develops, and sells medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. The company was founded in 1981 and is based in Danvers, Massachusetts.

ABMD Latest News Stream

Event/Time News Detail
Loading, please wait...

ABMD Latest Social Stream

Loading social stream, please wait...

View Full ABMD Social Stream

Latest ABMD News From Around the Web

Below are the latest news stories about Abiomed Inc that investors may wish to consider to help them evaluate ABMD as an investment opportunity.

Congestive Heart Failure (CHF) Treatment Devices Market to Hit Valuation of $14.8 Billion by 2022 | Abiomed, Inc., Berlin Heart GmbH

UPDATE AVAILABLE ON-DEMAND According to the research report published by Allied Market Research, the global Congestive Heart Failure (CHF) Treatment Devices market is expected to register a CAGR of 5.5% from 2016 to 2022. The research includes changing market dynamics, top

OpenPR | October 2, 2020

How To Avoid The Noise And Invest For Long-Term Success

Introduction I worked in the investment industry with experience at an investment firm (Primerica, Inc. before the spin-off from Citigroup) for a couple years; got job offers to work as a broker at many other entities, but ended up where I am today; working for a research oriented agency with...

James Sands on Seeking Alpha | September 21, 2020

DexCom: A Superior Business Model But Watch Out For Debt Level

DexCom’s (NASDAQ: DXCM) success can be attributed to the rapid adoption by the diabetic community of its innovative continuous glucose monitoring ("CGM") system. This disposable device worn on the body continuously downloads the patient's blood sugar to a smartphone and therefore provides patients with a convenient way to track their...

Chetan Woodun on Seeking Alpha | September 20, 2020

ABIOMED (ABMD) Earnings and Revenues Beat Estimates in Q1

ABIOMED's (ABMD) flagship Impella saw decline in revenues internationally and within the United States, in Q1.

Yahoo Finance | August 6, 2020

Abiomed's stock rises on second COVID-19-related EUA for heart pump

Shares of Abiomed Inc. undefined rallied 2.0% in premarket trading on Tuesday after the company said its Impella heart pump had received an emergency use…

MarketWatch | August 4, 2020

Read More 'ABMD' Stories Here

ABMD Price Returns

1-mo -3.29%
3-mo -16.02%
6-mo 39.16%
1-year 16.19%
3-year 33.35%
5-year 229.25%
YTD 47.65%
2019 -47.52%
2018 73.44%
2017 66.32%
2016 24.81%
2015 137.20%

Continue Researching ABMD

Here are a few links from around the web to help you further your research on Abiomed Inc's stock as an investment opportunity:

Abiomed Inc (ABMD) Stock Price | Nasdaq
Abiomed Inc (ABMD) Stock Quote, History and News - Yahoo Finance
Abiomed Inc (ABMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.7219 seconds.